Discussion Archives

Thursday Apr. 21, 2016: Impact of Patenting and Financial Interests in Academic Research

What is the mandate of publicly funded research institutions? What are the legal, practical, and ethical implications of universities retaining control of their inventions?

5pm in L-206 (BU medical campus), led by Mike Quintin.

Thursday Mar. 24, 2016: A Science Policy Career Discussion

4pm on the Charles River Campus, led by our advisor Dr. Sarah Hokanson

Thursday Feb. 25, 2016: Personalized Medicine

How heavily should companies offering genetic testing for disease-related biomarkers be regulated by the FDA?

5pm in L-206 (BU medical campus), led by Erin Bove-Fenderson

Erin’s summary:

The subject of personalized medicine is rich with public and science policy issues, including regulation of data use and establishing test standards.  We could return to the subject to discuss any of these nuances, but for this particular discussion I would like to talk about FDA oversight and regulation of consumer genomics.  The overarching question we will be discussing is: How heavily should companies offering genetic testing for disease-related biomarkers be regulated by the FDA?

Reading:

Wednesday, Jan. 20, 2016: Artificial Intelligence

2 Cummington Mall, Rm109 at 5pm